3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Polycystic Ovary Syndrome
8
Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Leukoplakia, Oral
2
Erythroplasia
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
TP53 Y220C Mutation
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Prostate Cancer Recurrent
1
Prediabetic State
1
Posterior Fossa Ependymal Tumor
1
Pleural Effusion, Malignant
1
Ovarian Neoplasms
1
Obesity
1
Neoplasms by Site
1
Neoplasms
1
Mouth Neoplasms
1
Metabolic Diseases
1
Melanoma
1
Medulloblastoma
1
Insulin Resistance
1
Infertility
1
Hyperplasia
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Interventions
pembrolizumab
2
durvalumab
2
Tretinoin
2
Paclitaxel
2
Oxaliplatin
2
Irinotecan
2
Chemoradiotherapy
2
Carboplatin
2
Capecitabine
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
tislelizumab
1
tegafur-gimeracil-oteracil
1
talazoparib
1
sarilumab
1
relugolix
1
pexidartinib
1
pertuzumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
enzalutamide
1
dostarlimab
1
cemiplimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Metformin
×
90 days
×
Clear all
No trials found.